Why is this ASX 200 stock jumping 14% today?

A big loss isn't stopping investors from buying this stock today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Nufarm shares jumped 14% today following its FY 2025 results, where the company reported an 18% increase in Crop Protection EBITDA despite a 3% decline in total underlying EBITDA due to setbacks in Seed Technologies and Omega-3 losses.
  • The company recorded a statutory net loss after tax of $165.3 million, reflecting significant non-cash material items, but emphasised a strong performance in Crop Protection across all regions, particularly Asia and Europe.
  • Looking ahead, Nufarm is optimistic about EBITDA growth and cash generation in FY 2026, with expectations to reduce leverage significantly, driven by improved earnings and cash flow management, underpinned by a focused strategy in Seeds and Bioenergy.

Nufarm Ltd (ASX: NUF) shares are catching the eye on Wednesday.

In morning trade, the ASX 200 stock is up 14% to $2.44.

Happy teen friends jumping in front of a wall.

Image source: Getty Images

Why is this ASX 200 stock jumping?

Investors have been bidding this agricultural chemicals company's shares higher today following the release of its FY 2025 results.

According to the release, Nufarm reported a 3% decline in underlying EBITDA (uEBITDA) to $302.5 million for the 12 months.

The company posted an 18% increase in Crop Protection uEBITDA in FY 2026. Management notes this reflects reduced deflationary pressure on selling prices as the year progressed, as well as benefits from an improved mix.

Offsetting its Crop Protection growth was its Seed Technologies business, which posted uEBITDA of $13.9 million. This is down from $62.6 million a year earlier. This reflects losses in Omega-3, which was negatively affected by a decline in fish oil prices.

Excluding the impact of the emerging Omega-3 and Bioenergy platforms, the ASX 200 stock's uEBITDA would have been up 10% on the prior corresponding period.

On a statutory basis, Nufarm recorded a net loss after tax of $165.3 million. This includes $142.4 million of predominantly non-cash material items resulting from the review of Seed Technologies and performance improvement plan.

Unsurprisingly, the company's dividend remains suspended and no final dividend was declared for FY 2025.

The ASX 200 stock's CEO, Greg Hunt, who has announced plans to step down in January, said:

Our crop protection business performed very well in FY25, with underlying earnings up 18% and growth across all regions including a record performance in Asia and a material turnaround in performance in Europe. We have a reprioritised strategy in Seed Technologies, with lower costs and capital requirements, a clear focus on growing hybrid seeds, expanding Bioenergy and reducing cash requirements for Omega-3.

Outlook

Nufarm believes that it is positioned for uEBITDA growth and positive cash generation in FY 2026. It also expects its leverage to reduce to 2.0 by end of the financial year, supported by growth in earnings and positive free cash flow.

Hunt adds:

We made good progress on cost and working capital and delivered a significant reduction in net debt from the first half. Net debt is below the level anticipated in our August update, a strong demonstration of our ability to deleverage through internal discipline and efficiency. In FY26, we have good momentum in Crop Protection, clear direction and opportunity in Seed Technologies and are well placed to grow earnings, generate cash and reduce leverage.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Woman looking at a laptop and thinking.
ASX Share Market News

ASX shares investors are still buying despite volatility: survey

The ASX 200 has slipped into the red for 2026.

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

Buy, hold, sell: Aurizon, Car Group, Guzman y Gomez shares

Toby Grimm from Baker Young explains his views and ratings on three ASX 300 shares.

Read more »

Broker looking at the share price.
Broker Notes

Buy, hold, sell: Temple & Webster, Kelsian, Boss Energy shares

Two experts share their views on three ASX shares.

Read more »

Two boys looking at each other while standing by the start line with two schoolgirls.
ASX Share Market News

ASX 200 rebounds from recent lows. Is this just another false start?

The rebound is a welcome change, but it may be too early to celebrate.

Read more »

A man in a business suit holds his coffee cup aloft as he throws his head back and laughs heartily.
Broker Notes

3 ASX 200 shares forecast to fly 30% to 40% higher

Here's the latest broker forecasts.

Read more »

A mother and her two adult daughters embrace outdoors.
Broker Notes

Buy, hold, sell: AGL Energy, Telstra, Zip shares

Here are brokers' latest verdicts on these three major ASX 200 shares.

Read more »

Press conference set up with symbol and flag of Federal Reserve.
ASX Share Market News

The Fed just hiked rates for the first time in 3 years. What does it mean for ASX investors?

The Fed’s latest move could keep markets on edge.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

This ASX biotech could jump more than 30%, one broker says

This company's core business is performing well, the broker says.

Read more »